The Role of Uric Acid in Stroke: The Issue Remains Unresolved.
<div class="page"><strong>Page: </strong><span>238</span></div><div class="doi"><strong>DOI: </strong><span>10.1097/NRL.0b013e31815c666b</span></div><div class="authors"><strong>Authors: </strong><span>Dimitroula, Hariklia V. MD; Hatzitolios, Apostolos I. PhD; Karvounis, Haralambos I. PhD</span></div>
The Promise and Potential Pitfalls of Serum Biomarkers for Ischemic Stroke and Transient Ischemic Attack.
<div class="page"><strong>Page: </strong><span>243</span></div><div class="doi"><strong>DOI: </strong><span>10.1097/NRL.0b013e31815a9945</span></div><div class="authors"><strong>Authors: </strong><span>Jensen, Matthew B. MD *; Chacon, Marcus R. MD *; Sattin, Justin A. MD *; Aleu, Aitziber MD +; Lyden, Patrick D. MD +</span></div>
10 Questions About Statins and Stroke.
<div class="page"><strong>Page: </strong><span>262</span></div><div class="doi"><strong>DOI: </strong><span>10.1097/NRL.0b013e31816606cc</span></div><div class="authors"><strong>Authors: </strong><span>Goldstein, Larry B. MD, FAAN, FAHA</span></div>
Clinical Predictors of Psychogenic Nonepileptic Seizures: A Critically Appraised Topic.
<div class="page"><strong>Page: </strong><span>266</span></div><div class="doi"><strong>DOI: </strong><span>10.1097/NRL.0b013e31817acee4</span></div><div class="authors"><strong>Authors: </strong><span>Hoerth, Matthew T. MD *; Wellik, Kay E. MLS, AHIP +; Demaerschalk, Bart M. MD, MSc, FRCP(C) *; Drazkowski, Joseph F. MD *; Noe, Katherine H. MD, PhD *; Sirven, Joseph I. MD *; Wingerchuk, Dean M. MD, MSc, FRCP(C) *</span></div>
Latest Neurology / Neuroscience News From Medical News Today.
News From The Journal Of Neuroscience 1. Modeling Electrophysiological Diversity Variations in morphology and ion-channel expression largely determine the electrophysiological properties of neurons. To investigate whether such variations are sufficient to explain the electrophysiological variability of globus pallidus neurons recorded in brain slices, Gunay et al. created more than 100,000 computer models using three realistic morphologies and variable levels of nine ionic conductances.
Children's Memorial Hospital Of Chicago Receives A Grant From BioMarin To Support Adult PKU Outreach Children's Memorial Hospital of Chicago has announced that it has received a grant from BioMarin Pharmaceutical Inc. to support its Adult Phenylketonuria (PKU) Outreach Education Project. The goal of the program is to conduct outreach to PKU patients who are no longer being treated at PKU clinics to encourage them to return for further education about recent developments in the management and treatment of PKU.
CyGene Laboratories Launches StrokeScan™ DNA Analysis CyGene Laboratories Inc. (OTC:CYGE) ("the Company") announced today that it is introducing StrokeScan™, a genetic screening test aimed at identifying high risk individuals who have a family history of stroke, cardiovascular or kidney disease. Offered at $499, StrokeScan™ analyzes genes that have been associated with the increased risk of stroke and the "alpha-galactosidase A" gene that is responsible for Fabry disease.
Mouse Spatial Recognition Memory Significantly Disrupted By Extremely Low-Frequency Magnetic Fields Exposure to extremely low frequency (ELF) magnetic fields is known to disrupt spatial cognition. Researchers found that mice exposed to extremely low ELFs over a long period had a significant disruption in spatial recognition memory. In the study, mice were exposed to 25 or 50 Hz of electromagnetic fields for either 7 or 25 days, and then tested in the Y-maze.
Scientists Figure Out How The Immune System And Brain Interact To Control Disease In a major step in understanding how the nervous system and the immune system interact, scientists at The Feinstein Institute for Medical Research have identified a new anatomical path through which the brain and the spleen communicate. The spleen, once thought to be an unnecessary bit of tissue, is now regarded as an organ where important information from the nervous reaches the immune system.
MIT Identifies Cells For Spinal-Cord Repair - Could Lead To Non-Surgical Treatment For Injuries A researcher at MIT's Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries.
Neuropathic Pain - NSL-043 Achieves Success In Phase I Multiple Ascending Dose Trial NeuroDiscovery Ltd (ASX: NDL), a specialty neuroscience services provider and drug development company, is pleased to announce the successful completion of its Phase I multiple ascending dose clinical trial of NSL-043. This trial is the second of two Phase I trials, designed to test the safety, tolerability and pharmacokinetics of an oral formulation of NSL-043 for the treatment of neuropathic pain.
Possible Geographical Ties To ALS Cases Among 1991 Gulf War Veterans Researchers from Duke University, the University of Cincinnati (UC) and the Durham Veterans Administration Medical Center are hoping to find a geographical pattern to help explain why 1991 Gulf War veterans contracted the fatal neurological disease amyotrophic lateral sclerosis (ALS) at twice the normal rate during the decade after the conflict.
Study Shows Promising Results In Deep Brain Stimulation For Treatment-Resistant Depression New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.
Outcomes Of Deep Brain Stimulation For Depression Sustained For One Year Canadian researchers have verified that deep brain stimulation (DBS) is a safe, new approach that has shown tremendous results for patients with treatment-resistant depression. Published online, in Biological Psychiatry, the study, lead by Dr.
Epilepsy Drug May Increase Risk Of Birth Defects Taking the epilepsy drug topiramate alone or along with other epilepsy drugs during pregnancy may increase the risk of birth defects, according to a study published in the July 22, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology. Research has shown that many epilepsy drugs increase the risk of birth defects, but little research has been done on topiramate.
Chemical Changes In The Brain Make Pregnant Mice Ignore The Smell Of Males Mouse mothers-to-be have a remarkable way to protect their unborn pups. Because the smell of a strange male's urine can cause miscarriage and reactivate the ovulatory cycle, pregnant mice prevent the action of such olfactory stimuli by blocking their smell. Researchers from the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, have now revealed the nature of this ability.
Children's Early Cognitive Development Influenced By Family Resources, Parenting Quality Even among low-income families, mothers with greater social and economic resources were more supportive in parenting their children than those with fewer resources, which in turn influenced the children's cognitive performance. That's the main finding of a new study that considers how economic factors and parenting quality jointly influence children's development.
DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals.
The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider.
The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
